JPY 2285.0
(-0.17%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 5.18 Billion JPY | 43.0% |
2022 | 3.62 Billion JPY | 58.62% |
2021 | 2.28 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 1.59 Billion JPY | 12.66% |
2024 Q2 | 1.97 Billion JPY | 23.92% |
2023 FY | - JPY | 43.0% |
2023 Q4 | 1.41 Billion JPY | 12.31% |
2023 Q3 | 1.25 Billion JPY | -9.94% |
2023 Q2 | 1.39 Billion JPY | 25.72% |
2023 Q1 | 1.11 Billion JPY | -3.14% |
2022 Q4 | 1.14 Billion JPY | 43.68% |
2022 Q3 | 799 Million JPY | 0.0% |
2022 FY | - JPY | 58.62% |
2021 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
JINS HOLDINGS Inc. | 10.26 Billion JPY | 49.483% |
Medius Holdings Co., Ltd. | 3.86 Billion JPY | -34.172% |
Ship Healthcare Holdings, Inc. | 31.88 Billion JPY | 83.743% |
JTEC Corporation | 437.18 Million JPY | -1085.553% |
Hogy Medical Co.,Ltd. | 10.77 Billion JPY | 51.902% |
Kawamoto Corporation | 944.44 Million JPY | -448.786% |
Terumo Corporation | 219.66 Billion JPY | 97.64% |
KAINOS Laboratories, Inc. | 1.05 Billion JPY | -390.917% |
Sysmex Corporation | 115.67 Billion JPY | 95.519% |
JMS Co.,Ltd. | 3.44 Billion JPY | -50.406% |
Nakanishi Inc. | 32.3 Billion JPY | 83.954% |
Mani, Inc. | 10.69 Billion JPY | 51.556% |
Olympus Corporation | 180.16 Billion JPY | 97.123% |
HOYA Corporation | 260.44 Billion JPY | 98.01% |
SEED Co.,Ltd. | 4.88 Billion JPY | -6.197% |
Asahi Intecc Co., Ltd. | 31.85 Billion JPY | 83.729% |
Medikit Co.,Ltd. | 6.31 Billion JPY | 17.988% |
Daiken Medical Co., Ltd. | 1.65 Billion JPY | -212.713% |
Menicon Co., Ltd. | 16.9 Billion JPY | 69.331% |
Sincere Co., LTD. | 391 Million JPY | -1225.575% |
Platz Co., Ltd. | 267.15 Million JPY | -1840.094% |
Paramount Bed Holdings Co., Ltd. | 23.4 Billion JPY | 77.859% |
Shofu Inc. | 5.87 Billion JPY | 11.824% |
Shigematsu Works Co., Ltd. | 1.38 Billion JPY | -274.158% |
Nipro Corporation | 81.2 Billion JPY | 93.618% |
ASO International, Inc. | 602.47 Million JPY | -760.286% |